The effect of maternal serum sFAS/sFASL system on etiopathogenesis of preeclampsia and severe preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 2016, Issue , 2016, Pages 1-11

  Bayram, M ^a   Taskaya, A ^a   Bagriacik, E U ^a   Ilhan, M N ^a   Yaman, M ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85136389347     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.722710     Document Type: Article

References (27)

1. 1-ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159-67
2. Kilpatrick DC, Liston WA, Gibson F, Livingstone J. Association between susceptibility to pre-eclampsia within families and HLA DR4. Lancet. 1989;2(8671):1063-5
3. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol. 2008;199(5):566.e1-11
4. rd Edition. Chap.34,2010:706– 756
5. Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989;257(4 Pt 2):R847-53
6. D'Anna R, Baviera G, Corrado F, Crisafulli A, Ientile R, Buemi M,Squadrito F. Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG. 2004;111(10):1046-50
7. Morris NH, Eaton BM, Dekker G. Nitric oxide, the endothelium, pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1996;103(1):4-15
8. Saito S, Sshiozaki A, Nakashima A, Sakai M, Sasaki Y.The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28(2):192-209
9. Zusterzeel PL,Rütten H, Roelofs HM, Peters WH, Steegers EA. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative strees. Placenta. 2001;22(2-3):213-219
10. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52(11):2682-9
11. Anton L, Merrill DC, Neves LA, Diz DI, Corthorn J, Valdes G, Stovall K, Gallagher PE, Moorefield C, Gruver C, Brosnihan KB. The uterine placental bed Renin-Angiotensin system in normal and preeclamptic pregnancy. Endocrinology. 2009;150(9):4316-25
12. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet. 1999; 33: 29–55
13. El-Sherbiny W, Soliman A, El-Mazny A. Elevated serum-soluble Fas in preeclampsia: correlation with clinical, laboratory, and Doppler parameters. Hypertens.Pregnancy. 2011;30:221-30.
14. Karthikeyan VJ, Lip GY, Baghdadi S, Lane DA, Beevers DG, Blann AD. Soluble Fas and Fas ligand in pregnancy: influence of hypertension. Angiology 2012;63:35-38.
15. Hsu CD, Harirah H, Basherra H, Mor G. Serum soluble Fas levels in preeclampsia. Obstet Gynecol. 2001;97:530-32.
16. Neale D, Demasio K, Illuzi J, Chaiworapongsa T, Romero R, Mor G. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonatal Med. 2003; 13 (1): 39-44
17. Hammer A, Dohr G. Expression of Fas-ligand in first trimester and term human placental villi. J Reprod Immunol. 2000; 46 (2): 83-90
18. Ashton SV, Whitley GS, Dash PR, Wareing M, Crocker IP, Baker PN, Cartwright JE. Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions. Arterioscler Thromb Vasc Biol. 2005;25(1):102-8
19. Ciarmela P, Boschi S, Bloise E, Marozio L, Benedetto C, Castellucci M, Petraglia F. Polymorphisms of FAS and FAS ligand genes in preeclamptic women. Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):144-6.
20. Belkacemi L, Chen CH, Ross MG, Desai M. Increased placental apoptosis in maternal food restricted gestations: role of the Fas pathway. Placenta. 2009 Sep;30(9):739-51
21. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy--its relevance for pre-eclampsia. Placenta. 1999; 20 (7): 531-9
22. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105(6):632-40
23. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597-602
24. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96:271-76.
25. Hu WS, Wang ZP, Dong MY, Wang HZ.Expression of Fas and FasL in serum and placenta of preeclamptic pregnancy and its significance. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005 Nov;34(6):499-502
26. Laskowska M, Laskowska K, Leszczyńska-Gorzela B, Oleszczuk J.Evaluation of the maternal and umbilical vein serum sFas/sFasL system in pregnancies complicated by preeclampsia with intrauterine growth retardation. EJOGRB. 2006;126(2):155-159
27. Kuntz TB, Christensen RD, Stegner J, Duff P, Koenig JM. Fas and Fas ligand Expression in Maternal Blood and in Umbilical Cord Blood in Preeclampsia. Pediatr Res. 2001;50(6):743-9